Central Venous Catheter-related Infection
📧 Sign up to get email alerts when something new happens for Central Venous Catheter-related Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Dressing Impregnated With Chlorhexidine and Vancomycin for the Prophylaxis of Central Venous Catheter-related Infections - a Randomized Trial [Phase 3]
A Phase 3 randomized trial evaluated a dressing impregnated with chlorhexidine and vancomycin to prevent central venous catheter-related inf…
-
FDA approval · 2023-11-15FDA Approved: DEFENCATH — Original Application (CorMedix Inc.)
Defencath is a taurolidine and heparin catheter-lock solution that received FDA approval via CorMedix's original NDA.